GlassScriptPhysician profile
Lalanica Chandrasekera
NPI 1508244914
$3,400.71
in general payments reported to CMS, 2019-2025
30 companies · $443 in 2025
The $443 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $504 · 2020: $864 · 2021: $225 · 2022: $297 · 2023: $622 · 2024: $447 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,511.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,510.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $799.55 | 2019-2025 | Perclot, Tisseel, Floseal |
| Covidien LP | $564.88 | 2020 | |
| Abbvie INC. | $317.34 | 2020-2023 | Lo Loestrin Fe, Orilissa |
| Boston Scientific Corporation | $197.99 | 2019 | |
| Coopersurgical, INC. | $132.26 | 2021-2023 | Advincula Delineator Uterine Manipulator |
| Mayne Pharma Commercial LLC | $129.48 | 2023-2025 | |
| Amgen INC. | $124.40 | 2025 | Evenity |
| Dysis Medical, INC. | $120.41 | 2023 | Dysis V3 Digital Coploscope, Dysis View, Dysis Ultra 2.0 |
| Pacira Pharmaceuticals Incorporated | $118.17 | 2019 | |
| Medtronic, INC. | $98.66 | 2022 | |
| Pfizer INC. | $97.59 | 2020-2024 | |
| Exact Sciences Corporation | $63.34 | 2024-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $63.13 | 2019-2021 | |
| Evofem Biosciences, INC. | $56.93 | 2020-2025 | Solosec, Phexx, Phexxi |
| Sumitomo Pharma America, INC. | $56.16 | 2024-2025 | Myfembree |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $54.27 | 2023-2025 | Nuvessa, Nuvessa, Slynd |
| Intuitive Surgical, INC. | $52.53 | 2022 | |
| Smith+Nephew, INC. | $47.63 | 2019-2024 | Pico 7 |
| Hologic Sales and Service, LLC | $39.48 | 2021-2024 | Thinprep 2000 Processor, Aptima |
| Millicent US INC | $38.24 | 2023-2024 | Femring, Intrarosa |
| Therapeuticsmd, INC. | $36.79 | 2020 | |
| Allergan, INC. | $28.75 | 2020 | |
| Astellas Pharma US INC | $27.89 | 2024 | Veozah |
| Dexcom, INC. | $23.71 | 2025 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $22.71 | 2023 | Accrufer |
| Lupin INC. | $20.25 | 2020 | |
| Daiichi Sankyo INC. | $19.77 | 2020 | |
| Amag Pharmaceuticals, INC. | $19.37 | 2019 | |
| Northgate Technologies, INC. | $15.51 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lalanica Chandrasekera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.